Ruffo D. Junior-Freitas

Goiania, GO, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Survival After Multimodal Treatment for Breast Cancer in Brazil: The Predominant Role of Clinical Stage and Treatment Response.

Survival After Multimodal Treatment for Breast Cancer in Brazil: The Predominant Role of Clinical Stage and Treatment Response.

Journal: Clinical breast cancer

Published: February 26, 2026

Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.

Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.

Journal: The New England journal of medicine

Published: January 21, 2026

Prevalence of actionable pharmacogenomic variants in Brazilian patients with cancer.

Prevalence of actionable pharmacogenomic variants in Brazilian patients with cancer.

Journal: Frontiers in pharmacology

Published: October 31, 2025

Vacuum-assisted excision: one-step approach to the diagnosis and percutaneous treatment of small early breast cancer (the VAE-BREAST 01 study protocol).

Vacuum-assisted excision: one-step approach to the diagnosis and percutaneous treatment of small early breast cancer (the VAE-BREAST 01 study protocol).

Journal: Frontiers in oncology

Published: August 18, 2025

Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study.

Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study.

Journal: ESMO open

Published: July 08, 2025

Capivasertib plus paclitaxel as first-line treatment for metastatic triple-negative breast cancer: Results from the randomised, global phase III CAPItello-290 trial.

Capivasertib plus paclitaxel as first-line treatment for metastatic triple-negative breast cancer: Results from the randomised, global phase III CAPItello-290 trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: June 12, 2025

Determinants of delayed postoperative radiation therapy in breast cancer patients undergoing neoadjuvant chemotherapy: A subanalysis of the AMAZONA III prospective cohort.

Determinants of delayed postoperative radiation therapy in breast cancer patients undergoing neoadjuvant chemotherapy: A subanalysis of the AMAZONA III prospective cohort.

Journal: Cancer treatment and research communications

Published: May 05, 2025

Clinical characteristics and prognostic impact of HER2 low expression in breast cancer subtypes from a Brazilian real-world cohort.

Clinical characteristics and prognostic impact of HER2 low expression in breast cancer subtypes from a Brazilian real-world cohort.

Journal: Scientific reports

Published: March 16, 2025

Germline Genetic Testing in Breast Cancer: Utilization and Disparities in a Middle-Income Country.

Germline Genetic Testing in Breast Cancer: Utilization and Disparities in a Middle-Income Country.

Journal: JCO global oncology

Published: March 07, 2025

Cracking the code: Pioneering early detection and management of breast cancer in the Brazilian public healthcare system.

Cracking the code: Pioneering early detection and management of breast cancer in the Brazilian public healthcare system.

Journal: Dialogues in health

Published: February 23, 2025

National Survey on Attitudes of Brazilian Breast Surgeons Regarding Oncoplastic Surgery: Success of a Training Model.

National Survey on Attitudes of Brazilian Breast Surgeons Regarding Oncoplastic Surgery: Success of a Training Model.

Journal: Annals of surgical oncology

Published: January 23, 2025

Breast cancer stage, molecular subtype and survival in patients with obesity: a real-world study.

Breast cancer stage, molecular subtype and survival in patients with obesity: a real-world study.

Journal: Chinese clinical oncology

Published: December 22, 2024

Showing 1-12 of 92

Last Updated: 09/26/2026